Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.
Ontology highlight
ABSTRACT: The emergence and seasonal persistence of pathogenic H7N9 influenza viruses in China have raised concerns about the pandemic potential of this strain, which, if realized, would have a substantial effect on global health and economies. H7N9 viruses are able to bind to human sialic acid receptors and are also able to develop resistance to neuraminidase inhibitors without a loss in fitness. It is not clear whether prior exposure to circulating human influenza viruses or influenza vaccination confers immunity to H7N9 strains. Here, we demonstrate that 3 of 83 H3 HA-reactive monoclonal antibodies generated by individuals that had previously undergone influenza A virus vaccination were able to neutralize H7N9 viruses and protect mice against homologous challenge. The H7N9-neutralizing antibodies
SUBMITTER: Henry Dunand CJ
PROVIDER: S-EPMC4362269 | biostudies-literature | 2015 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA